~~<i id='99456071C0'><strike id='99456071C0'><tt id='99456071C0'><pre id='99456071C0'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

knowledge

author：leisure time 2025-09-27 21:54:42 - browse：59775

A European regulatory panel has recommended against approval of a lung cancer drug made by Mirati Therapeutics, the company said Friday.

Mirati said it will appeal the negative opinion of the drug, called Krazati, issued by a committee of the European Medicines Agency that met this week. But for now, the adverse decision is likely to be adopted by European regulators and prevent the company from marketing the pill in Europe.

Krazati works by blocking a specific type of KRAS alteration called G12C, found in approximately 13% of lung tumors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Woodcock on FDA’s accelerated approval and her next chapter

entertainment

leisure time

explore

Wikipedia

hotspot

AbrainaffectedbyAlzheimer'sdisease,attheMuseumofNeuroanatomyattheUniversityatBuffalo.DavidDuprey/API

WSS

General Catalyst, Summa Health deal will turn on physician buy

SAMSHA loosens regulations on methadone treatment centers

General Catalyst, Summa Health deal will turn on physician buy

A $475,000 price tag for a new cancer drug: crazy or meh?

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Listen: PBM conflicts, RSV vaccines, & the future of flu season

entertainment

knowledge

entertainment

Continuity nursing helped my family in our darkest PICU moments

Novo Nordisk to expand supply of Wegovy for U.S. patients

Walensky prepares to leave CDC — and Congress — behind

Do digital therapeutics have a future in medicine?

Supreme Court strikes down use of affirmative action

SAMSHA loosens regulations on methadone treatment centers

Medicare proposal to cover medical devices draws a mixed reaction

Connecting traumatic brain injury and domestic violence

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Cognito secures funding to test medical device for Alzheimer's

leisure time

Vertigo drug brings hope for rare neuron disorder, Niemann

PhRMA sues HHS over Medicare drug price negotiation

Pfizer's Covid pill remains 89% effective in final analysis, company says

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

Brain 'hot spot' may explain why African Americans feel greater pain

SAMSHA loosens regulations on methadone treatment centers

explore

Wikipedia

hotspot

hotspot